Finance

Beta
Lists
140410:KOSDAQ
Mezzion Pharma Co Ltd
â‚©59,500.00
-4.34%
(-2,700.00) 1D
Jun 8, 3:30:11 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 140410...
Open
â‚©58,400
High
â‚©63,500
Low
â‚©57,200
Mkt. cap
1.81T
Avg. vol.
198.37K
Volume
192.26K
52-wk high
â‚©179,900
52-wk low
â‚©35,850
EPS
-â‚©1,219
Shares outstanding
30.39M
No. of employees
18
Open
â‚©58,400
High
â‚©63,500
Low
â‚©57,200
Mkt. cap
1.81T
Avg. vol.
198.37K
Volume
192.26K
52-wk high
â‚©179,900
52-wk low
â‚©35,850
EPS
-â‚©1,219
Shares outstanding
30.39M
No. of employees
18
News stories
From sources across the web
About Mezzion Pharma Co Ltd
CEODean Park
Employees18
Founded2002
Headquarters-
SectorPharmaceutical industry
Websitemezzion.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.74B
2.13B
2.08B
2.02B
Cost of goods sold
1.40B
1.74B
1.79B
1.67B
Cost of revenue
1.40B
1.74B
1.79B
1.67B
Research and development expenses
-
129.68M
449.03M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.64B
4.67B
4.74B
4.69B
Operating expense
3.89B
5.04B
5.42B
4.91B
Total operating expenses
5.29B
6.78B
7.21B
6.58B
Operating income
-3.55B
-4.65B
-5.12B
-4.56B
Other non operating income
-260.30M
-46.91M
-20.91B
-31.55M
EBT including unusual items
-3.81B
-5.13B
-26.59B
-5.31B
EBT excluding unusual items
-3.82B
-5.16B
-26.59B
-5.31B
Income tax expense
-1.96B
-
-1.95B
-
Effective tax rate
51.42%
-
7.34%
-
Other operating expenses
-
-
-
-
Net income
-1.85B
-5.13B
-24.64B
-5.31B
Net profit margin
-106.08%
-241.07%
-1,182.14%
-263.34%
Earnings per share
-
-
-
-
Interest and investment income
101.31M
195.74M
177.15M
44.40M
Interest expense
-129.07M
-646.50M
-722.23M
-736.54M
Net interest expenses
-27.76M
-450.76M
-545.08M
-692.14M
Depreciation and amortization charges
249.82M
240.38M
234.72M
195.06M
EBITDA
-3.30B
-4.41B
-4.89B
-4.37B
Gain or loss from assets sale
-12.58M
-31.26M
-209.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer